Drug Law Weekly

CeNeRx BioPharma, Inc. - Central nervous system disease-focused drug developer announces $18.5M Series A financing

Centre Hospitalier Lyon Sud, Pierre Benite - Comprehensive geriatric assessment predicted survival and chemotherapy tolerance

Centre Hospitalier Sainte-Anne, Paris - Oligodendrogliomas are heterogeneous tumors that deserve targeted therapy

Cephalon, Inc. - Novel compounds licensed by Bausch & Lomb for ophthalmic use

Children's Hospital of Michigan - MST can decrease inpatient admissions among youth with poorly controlled type 1 diabetes

Children's Hospital of Western Ontario - Better tasting medicine needed to treat children with HIV-AIDS

Cognet-X, Inc. - Three products are among the most promoted to managed care pharmacy executives

Coley Pharmaceutical Group, Inc. - Phase III clinical trials of PF-3512676 for advanced NSCLC begins

Columbia University, New York - Resveratrol treatment during storage reduces vein graft endothelial damage

Cornell University, Weill Medical College, Ithaca - Vaginally delivered SIV-cell fusion inhibitors protect macaques from SHIV infection

Cornell University, Weill Medical College, New York - Antibiotic inhibits siderophore biosynthesis in M. tuberculosis and Y. pestis

Covance Laboratories, Inc. - Metabolic stability assessment and metabolite screening performed at same time

Creighton University, Omaha - Antiplatelet drug resistance inadequately defined

Cubist Pharmaceuticals, Inc. - Cubicin maker selects ACS Dobfar as single-source API supplier

Cubist Pharmaceuticals, Inc. - U.S. FDA accepts Cubicin sNDA and grants priority review

Cytogen Corp. - Combination of Quadramet and new proteasome inhibitor to be evaluated in new clinical trial

Daichi Sankyo Company, Limited - Trial data on hyperlipidemia drug mevalotin show artery disease significantly suppressed

Deakin University, Geelong - Australian school children need less junk food in lunchboxes

Decision Resources, Inc. - Research firm study expects arthritis pain treatment market to decline 5% annually through 2009

Dendreon Corp. - U.S. FDA agrees to special protocol assessment amendment to D9902B IMPACT study of Provenge

Drug Resistance - Gefitinib treats bronchioloalveolar carcinoma

Duke University, Durham - 'Computer-chemistry' gives new insight into the puzzle of cell division

Edwards Lifesciences Corp. - Heart valve company to restart U.S. percutaneous heart valve feasibility study

Facilities - Advanced Medical Institute expands New Zealand operations

Johnson & Johnson - New drug application submitted for paliperidone extended-release tablets

Journal of the American Medical Association - Serious adverse reactions to smallpox vaccine appear to be limited

LifeNet - U.S. FDA clears 510(k) premarket notice for family of bone void fillers

Longmark Industries, LLC - Food sanitation, consumer information plan launched to prevent food-borne illnesses

Medical College of Wisconsin - Researchers develop a possible broad-spectrum defense against germ warfare

Nottingham City Hospital - Smaller cancers were diagnosed after arbitration of discordant double reading

Ox-Gen Flexible Life Systems, Inc. - Production to begin of non-pressurized oxygen system

Response Biomedical Corp. - LXU Healthcare to exclusively distribute Ramp cardiovascular tests

Schering-Plough Corp. - U.S. FDA approves new indication for Avelox (moxifloxacin HCl)

St. Francis Medical Technologies - U.S. FDA approves minimally invasive system to treat common degenerative spine disorder

U.S. Food & Drug Administration - Deletion of chrA/S C. diphtheriae genes causes heme sensitivity

U.S. Food & Drug Administration - Model averaging estimates effective doses for microbial infection

University of Chicago Children's Hospital - Intracardiac echocardiography useful in perimembranous defect closure

Washington University, St. Louis - Abuse of OxyContin in United States is on the increase

Zydus Cadila - India-based company receives approval for anti-emetic drug capsules from U.S. FDA